Aim: To investigate the effect of oral nifedipine on ocular blood flow in patients with low tension glaucoma (LTG).
Methods: In this prospective study we examined the effects of 3 weeks of treatment with oral nifedipine 30 mg/day in 11 patients with LTG, by using colour Doppler ultrasound imaging to measure haemodynamic variables in the central retinal (CRA), short posterior ciliary (SPCA), and ophthalmic (OA) arteries. Intraocular pressure (IOP) and blood pressures were also evaluated.
Results: Nifedipine failed to alter IOP nor did it change peak systolic velocity, end diastolic velocity,or the resistance index in any of the three ocular vessels studied (p > 0.05). However systolic and diastolic systemic arterial blood pressure measurements varied significantly after nifedipine treatment compared with baseline (p < 0.05).
Conclusion: Our study failed to demonstrate a significant effect of nifedipine on retrobulbar circulation of patients with LTG.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC505703 | PMC |
| http://dx.doi.org/10.1136/bjo.80.12.1060 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-acting nifedipine in the management of essential hypertension: a review for cardiologists.
Am J Cardiovasc Dis
December 2024
J.B. Chemicals and Pharmaceuticals Ltd. Cnergy It Park, Unit A, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra 400025, India.
Calcium channel antagonists, specifically long-acting nifedipine formulations, play a crucial role in treating hypertension and angina. Originally used for angina, nifedipine has been widely employed as an antihypertensive medication for over 40 years. It offers rapid action and oral bioavailability with minimal maternal or fetal side effects, making it suitable for treating hypertensive crises during pregnancy.
View Article and Find Full Text PDFOral antihypertensive agents and diuretics in the management of hypertension in postpartum women: a systematic review and meta-analysis.
BMJ Open
December 2024
Department of Obstetrics, University Medical Centre Utrecht, Utrecht, The Netherlands
Objective: In the puerperium, women with hypertensive disease of pregnancy remain at risk for maternal complications. The antihypertensive agent prescribed antepartum is usually continued postpartum; however, evidence regarding the most effective treatment is lacking. Therefore, we aimed to investigate which antihypertensive agent results in optimal treatment (both effectiveness and safety) of postpartum hypertension.
View Article and Find Full Text PDFDaily versus Twice Daily Nifedipine for Blood Pressure Control in Pregnancy and Postpartum.
Am J Perinatol
December 2024
Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York.
Article Synopsis
- The study aimed to compare the effectiveness of 60mg daily (QD) extended-release nifedipine versus 30mg twice daily (BID) for controlling blood pressure in pregnant patients before and after delivery.
- Conducted as a retrospective review at Mount Sinai Health System, the research included 237 patients with hypertensive disorders of pregnancy and evaluated the need for adjusting medication dosages.
- Results showed no significant differences in blood pressure management or emergency treatment needs between the two dosing regimens, suggesting that once-daily dosing may be more convenient for patients without compromising effectiveness.
CCN2: a potential contributor to gingival overgrowth.
J Oral Biosci
November 2024
College of Dentistry, University of Saskatchewan, 105 Wiggins Rd, Saskatoon, SK, Canada, S7H 2E5. Electronic address:
Background: Fibrotic responses in the gingiva are characterized by their hyperproliferative nature instead of scar tissue formation. Clinically, these conditions appear as "gingival overgrowth" (GO), which can be of drug-induced or genetic origin. Despite surgical removal, GO can recur.
View Article and Find Full Text PDFShort-Acting Oral Nifedipine versus Intravenous Labetalol for the Control of Severe Hypertension in the Postpartum Period: A Retrospective Cohort Study.
Am J Perinatol
October 2024
Department of Cardiology, Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California.
Objective: This study aimed to compare the effectiveness of oral short-acting (SA) nifedipine with intravenous (IV) labetalol for the treatment of postpartum (PP) severe hypertension.
Study Design: We conducted a retrospective cohort study of women who delivered at a tertiary care facility between January and December 2018, had not previously received antihypertensive medication, and required treatment for PP severe hypertension defined as systolic blood pressure (SBP) ≥ 160 mm Hg and/or diastolic blood pressure (DBP) ≥110 mm Hg. Exposure groups were defined by the receipt of either oral SA nifedipine or IV labetalol.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!